Recent data on the regulation of lipolysis by catecholamines and natriuretic peptides

Annales d'Endocrinologie

Volumn 63, Issue 2 I, 2002, Pages 86-90

  Lafontan, M ^a   Berlan, M ^a   Stich, V ^a   Crampes, F ^a   Riviere D ^a   De Glisezinski, I ^a   Sengenes, C ^a   Galitzky, J ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADRENALIN; ADRENERGIC RECEPTOR; ATRIAL NATRIURETIC FACTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; FATTY ACID; GLYCEROL; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE SENSITIVE LIPASE; HYDROCORTISONE; INSULIN; ISOPRENALINE; NATRIURETIC FACTOR; NORADRENALIN; PARATHYROID HORMONE; RECEPTOR SUBTYPE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADRENAL MEDULLA; CONFERENCE PAPER; ENERGY EXPENDITURE; FATTY ACID OXIDATION; GENETIC POLYMORPHISM; GLUCOSE TRANSPORT; INSULIN RESISTANCE; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LIPOLYSIS; MICRODIALYSIS; OBESITY; PROTEIN EXPRESSION; RECEPTOR DENSITY; REGULATORY MECHANISM; SEX DIFFERENCE; THERMOGENESIS;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINES; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPOLYSIS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; OBESITY;

EID: 0036109723     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. In situ assessment of the role of the β1-, β2- and β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue
2. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity
3. Resistance to the lipolytic action of epinephrine: A new feature of protein Gs deficiency
4. Skeletal muscle utilization of free fatty acids in women with visceral fat obesity
5. Endurance training changes in lipolytic responsiveness of obese adipose tissue
6. Lack of alpha2-adrenergic antilipolytic effect during exercise in subcutaneous adipose tissue of trained men
7. The subcutaneous lipolytic response to regional neural stimulation is reduced in obese women
8. Impaired in vivo stimulation of lipolysis in adipose tissue by selective β2-adrenergic agonist in obese adolescent girls
9. Role of vascular alpha2-adrenoceptors in regulating lipid mobilization from human adipose tissue
10. The lipid mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men
11. β-adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo
12. Gender differences in adrenergic regulation of lipid mobilization during exercice
13. Suppression of whole body and regional lipolysis by insulin: Effects of obesity and exercise
14. Gender differences in sympathetic nervous system regulation
15. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women
16. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridemia and diabetes mellitus
17. Abolition of (-)CGP12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knock out mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology
18. β1-adrenergic receptors mediate β3-adrenergic-independent effects of CGP12177
19. Adrenergic regulation of adipocyte metabolism
20. Fat cell α2-adrenoceptors: The regulation of fat cell function and lipolysis
21. Fat cell adrenergic receptors and the control of white and brown fat cell function
22. Human beta2-adrenoceptor gene polymorphism are highly frequent in obesity and associated with altered adipocyte beta2-adrenoceptor function
23. Characterization of β-adrenergic receptors in human skeletal muscle obtained by needle biopsy
24. Lipolytic catecholamine resistance due to decreased β2-adrenoceptor expression in fat cells
25. Regional variation in adipose tissue lipolysis in lean and obese men
26. Heterogeneous distribution of beta- and alpha2-adrenoceptor binding sites in human fat cells from various fat deposits: Functional consequences
27. Regional and gender variations in adipose tissue lipolysis in response to weight loss
28. Human fat cell beta-adrenergic receptors: Beta agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta1antagonists
29. Regional differences in adipose tissue lipolysis from lean and obese women: Existence of postreceptor alterations
30. Insulin regulation of regional free fatty acid metabolism
31. Impact of polymorphisms in the human β2-adrenoceptor gene on obesity in French population
32. β2-adrenoceptor gene polymorphism, body weight and physical activity
33. Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue
34. The GIn27GIu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation
35. Catecholamine resistance in fat cells of women with upper body obesity due to decreased expression of beta2-adrenoceptors
36. In vivo β3-adrenergic stimulation of human thermogenesis and lipid utilization
37. The effects of an increased NEFA concentration on thermogenesis and substrate oxidation in obese and lean men
38. β1- and β2-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men
39. Natriuretic peptides: A new lipolytic pathway in human adipocytes
40. Whole body fat oxidation is related to in situ adipose tissue lipolytic response to isoproterenol in males
41. Endurance training increases the β-adrenergic lipolytic response in subcutaneous adipose tissue in obese subjects
42. Activation of antilipolytic α2-adrenergic receptors by epinephrine during exercise in human adipose tissue
43. Activation of alpha2-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects
44. Expression of β3-adrenoceptors with low lipolytic action in human subcutaenous fat cells
45. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes